Data / Form D filings / Metagenomi Technologies, LLC
Metagenomi Technologies, LLC: Form D filings
Metagenomi Technologies, LLC, a biotechnology company in Emeryville, CA, filed 5 Form D notices with the SEC between 2019 and 2023. The latest, on January 11, 2023, reports $95.8 million sold of a $100 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1545 Park Avenue, Emeryville, CA, 94608
- Phone
- (510) 871-4880
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1785279
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | New notice | $99,999,964 | $95,790,739 | $4,209,225 | 25 | Dec 20, 2022 | sec.gov |
| Feb 7, 2022 | New notice | $175,374,794 | $175,374,794 | 29 | Jan 21, 2022 | sec.gov | |
| Mar 29, 2021 | New notice | $9,999,995 | $9,999,995 | 2 | Mar 15, 2021 | sec.gov | |
| Nov 25, 2020 | New notice | $40,200,000 | $37,544,506 | $2,655,494 | 11 | Nov 10, 2020 | sec.gov |
| Aug 16, 2019 | New notice | $27,273,177 | $26,373,182 | $899,995 | 16 | Aug 2, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Willard C. Dere | Director | |
| Brian C. Thomas | Executive Officer, Director | |
| Santhosh C. Palani | Director | |
| Risa C. Stack | Director | |
| Juergen C. Eckhardt | Director | |
| Sebastian C. Bernales | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 9, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Metagenomi Technologies, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.